Microfluidic Assaying of Circulating Tumor Cells and Its Application in Risk Stratification of Urothelial Bladder Cancer

Guanghou Fu(Zhejiang University), Baiye Jin(Zhejiang University), Yun Dai(University of Miami), Kok Suen Cheng(Peking University), Anqi Chen(Ningbo University), Xiaoyi Chen(China Pharmaceutical University), Zhijie Xu(First Affiliated Hospital Zhejiang University), Congcong Xu(First Affiliated Hospital Zhejiang University), Yukun Sun(Peking University), Ray P. S. Han(Jiangxi University of Traditional Chinese Medicine), Junjie Tian(Affiliated Hospital of Southwest Medical University), Kuang Hong Neoh(Peking University)
Frontiers in Oncology
June 10, 2021
10.3389/fonc.2021.701298
Cited by 18

Related Papers

Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors
|Frontiers in Immunology|2023|181
Bortezomib and flavopiridol interact synergistically to induce apoptosis in chronic myeloid leukemia cells resistant to imatinib mesylate through both Bcr/Abl-dependent and -independent mechanisms
|Blood|2004|123
CDCA5 functions as a tumor promoter in bladder cancer by dysregulating mitochondria-mediated apoptosis, cell cycle regulation and PI3k/AKT/mTOR pathway activation
|Journal of Cancer|2020|75
Statins synergistically potentiate 7-hydroxystaurosporine (UCN-01) lethality in human leukemia and myeloma cells by disrupting Ras farnesylation and activation
|Blood|2007|73
Modulation of G6PD affects bladder cancer via ROS accumulation and the AKT pathway in vitro
|International Journal of Oncology|2018|70